Your browser doesn't support javascript.
loading
Transcatheter Embolization of Type I Endoleaks Associated With Endovascular Abdominal Aortic Aneurysm Repair Using Ethylene Vinyl Alcohol Copolymer.
Graif, Assaf; Vance, Ansar Z; Garcia, Mark J; Lie, Kevin T; McGarry, Michael K; Leung, Daniel A.
Affiliation
  • Graif A; 1 Department of Vascular and Interventional Radiology, Christiana Care Health System, Newark, DE, USA.
  • Vance AZ; 1 Department of Vascular and Interventional Radiology, Christiana Care Health System, Newark, DE, USA.
  • Garcia MJ; 1 Department of Vascular and Interventional Radiology, Christiana Care Health System, Newark, DE, USA.
  • Lie KT; 1 Department of Vascular and Interventional Radiology, Christiana Care Health System, Newark, DE, USA.
  • McGarry MK; 1 Department of Vascular and Interventional Radiology, Christiana Care Health System, Newark, DE, USA.
  • Leung DA; 1 Department of Vascular and Interventional Radiology, Christiana Care Health System, Newark, DE, USA.
Vasc Endovascular Surg ; 51(1): 28-32, 2017 Jan.
Article in En | MEDLINE | ID: mdl-28100156
ABSTRACT

PURPOSE:

To evaluate the feasibility, safety, and outcome of transcatheter embolization using ethylene vinyl alcohol copolymer (EVOH) of type I endoleaks associated with endovascular abdominal aortic aneurysm repair. PATIENT POPULATION AND

METHODS:

Retrospective chart review was performed to identify 8 consecutive patients who had undergone EVOH embolization for type I endoleaks between 2012 and 2015. The primary approach used to access the endoleak was the perigraft technique, where the endoleak itself is catheterized at the anastomotic site.

RESULTS:

Six type Ia and 2 type Ib endoleaks were treated. In 2 patients, a direct transabdominal approach was used to access the endoleak because it was inaccessible via the perigraft approach. Coils were used in addition to EVOH in 5 cases. Residual endoleak was noted in 1 case, whereas 2 patients developed a recurrent type I endoleak during follow-up. No EVOH complications were observed. The 5 remaining patients demonstrated freedom from endoleak and reintervention at a mean follow-up of 6.9 months.

CONCLUSION:

Type I endoleaks can be safely and effectively treated by embolotherapy with EVOH. Larger endoleaks resulting from grossly undersized endografts appear to be unsuitable for EVOH embolization.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Polyvinyls / Aortic Aneurysm, Abdominal / Blood Vessel Prosthesis Implantation / Embolization, Therapeutic / Endoleak / Endovascular Procedures Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Vasc Endovascular Surg Journal subject: ANGIOLOGIA / CARDIOLOGIA Year: 2017 Document type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Polyvinyls / Aortic Aneurysm, Abdominal / Blood Vessel Prosthesis Implantation / Embolization, Therapeutic / Endoleak / Endovascular Procedures Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Vasc Endovascular Surg Journal subject: ANGIOLOGIA / CARDIOLOGIA Year: 2017 Document type: Article Affiliation country: United States